Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run
- 31 October 2004
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 73 (1) , 11-20
- https://doi.org/10.1016/j.radonc.2004.08.005
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy runRadiotherapy and Oncology, 2002
- Partial irradiation of the rectumSeminars in Radiation Oncology, 2001
- Late rectal bleeding after conformal radiotherapy of prostate cancer (II): volume effects and dose–volume histogramsInternational Journal of Radiation Oncology*Biology*Physics, 2001
- A comparison of coplanar four-field techniques for conformal radiotherapy of the prostateRadiotherapy and Oncology, 1999
- Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy runRadiotherapy and Oncology, 1995
- EORTC guidelines for writing protocols for clinical trials of radiotherapyRadiotherapy and Oncology, 1995
- Minumum requirements for quality assurance in radiotherapyRadiotherapy and Oncology, 1993
- The programme of quality assurance of the EORTC radiotherapy group. A historical overviewRadiotherapy and Oncology, 1993
- Workshop of the EORTC radiotherapy group on quality assurance in cooperative trials of radiotherapy: A recommendation for EORTC cooperative groupsRadiotherapy and Oncology, 1988
- Patterns of care studies: Dose-response observations for local control of adenocarcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1985